Even as we are driving the implementation of the production component of our innovative green biotechnology process, our scientific team continues to push the machine. The results are convincing.

Our scientific team delivers the goods.

Following the initial discovery of the full potential of our proprietary photosynthetic phytoreplicators, Mr. Mourad Sabri, Ph.D., our Chief Scientific Officer, and his beefed-up multidisciplinary team have maintained the pace. Aiming to offer sustainable solutions to the specific needs expressed by our current and potential clients for plant-based molecules, the multiple projects of our R&D program are bearing fruit. “Our intellectual property portfolio is buzzing with the filing of 3 new patents and 6 breeder’s rights. We are privileged to be able to rely on the proven expertise of Mr. George Elvira, Ph.D., partner and patent agent for Gowling WLG and a member of our advisory board, to successfully carry out this crucial step for our growth.” Mr. Patrick Charest, B.Sc., Eng., mMBA, CEO.

In the context of the explosion of pressures on current supply chains for plant-based molecules—climate change and geopolitical conflicts, among others—the interest of the cosmetic, nutraceutical, agri-food, and pharmaceutical industries in Aplantex’s innovative solution is growing. Based on the business intelligence shared with several new potential clients, our R&D portfolio is well-filled.

Share : Back to blog